transparency
flexibility
results
expect more...
Our proven process of combining clinical safety and efficacy with cost-effective therapy allows our clients to be more effective purchasers of medications. We have designed broad Preferred Drug Lists that give physicians a wide range of choices in caring for their patients, while delivering significant savings for our clients.
Provider Synergies creates a win-win situation by reducing the cost of therapy while maintaining clinically equivalent medications within a therapeutic class.
A Preferred Drug List (PDL) program that includes a rebate program will save significantly more money than a program without the rebate program. Given that a group of medications is clinically equivalent, rebates can greatly reduce the cost of therapy within a therapeutic class. Although savings can be realized from movement to lower AWP products within a therapeutic class, the majority of savings associated with a PDL program are achieved through a rebate program.
Complementary strategies to preserve savings include disease management, delivering better drug and patient level information to prescribers at the point of care and buying generic medications more efficiently. Along with implementation of such initiatives, the integration of a PDL with a Prior Authorization (PA) program provides for a seamless interface that assures provision of clinical excellence delivered in a cost-effective manner.
Transparency
Provider Synergies provides our clients with open, accurate and timely
information regarding clinical review, rebate generation and other
pharmacy benefit agreements.
Flexibility
Provider Synergies has worked successfully with multiple state claims
processors and prior authorization vendors, allowing our clients the
flexibility to choose the fiscal agents and other vendors that best
suit their needs. Coordination with the client's claims processor is
simplified by Provider Synergies' ability to modify its NDC-PDL reports
to meet the needs of the client.
Results
Provider Synergies demonstrates our expertise in developing integrated
Preferred Drug Lists (PDLs) and contracting strategies in our past
and current performance for our clients. Combining knowledge and understanding
of each client's goals together with full disclosure of the clinical
rationale and financial opportunities allows Provider Synergies and
its clients to more accurately predict the results of each decision
that is made.